BASF weighs higher Evonik offer: BASF stock gains 2.20 percent

Published on 10/14/2026 at 13:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BASF stock costs EUR 52.55 on October 14, 2026. The quote is 2.20 percent above the October 13 Xetra close of EUR 51.42.

Key event and earnings calendar

Reuters reported a potential EUR 22.15-per-share Evonik offer on October 9, 2026.
Analysts forecast EUR 15.70 billion in third-quarter revenue against EUR 14.33 billion a year earlier.
BASF stock trades at EUR 52.55 at 1:06 p.m. CEST at Lang & Schwarz on October 14, 2026, 2.20 percent above the Xetra close of October 13, 2026.

Vogelperspektive auf Laborgeräte, Notizbuch mit Molekülskizzen, Pipetten und Periodensystem auf weißem Untergrund — Overhead-Flatlay auf weißer Laborfläche: präzise arrangierte Erlenmeyerkolben, farbcodierte Pipetten, Petrischalen, ein aufgeschlagenes Labornotizbuch mit Molekülzeichnungen und Periodensystemkarte, ein Feinminenstift und Glasperlen. Gleichmäßiges Studiolichjt ohne Schatten. Im Notizbuch steht der Schriftzug CHEMISTRY. Minimalistisch, hochklar, Illustration mit AI erstellt.

BASF stock was trading at EUR 52.55 at Lang & Schwarz on October 14, 2026, at 1:06 p.m. CEST, up 2.20 percent versus the Xetra close of October 13, 2026 at EUR 51.42. The immediate corporate backdrop is the possible Evonik transaction, with the latest report pointing to a potential higher offer.

According to Reuters on October 9, 2026, sources close to BASF said the company could make a higher offer for Evonik. The reported approach was valued at EUR 22.15 per Evonik share, while BASF declined to comment.

Three dates define the story

On July 15, 2026, BASF reported second-quarter revenue of EUR 17.21 billion and earnings per share of EUR 4.78, compared with EUR 0.09 a year earlier, according to Investment Traders. On September 25, 2026, BASF confirmed exploratory talks with Evonik and the RAG Foundation. On October 9, 2026, Reuters reported that a higher offer remained possible, putting the EUR 22.15 approach back at the center of the takeover debate.

What do earnings expectations imply?

The next test is the third-quarter report. A finanzen.net survey published October 13, 2026, put expected revenue for the quarter ended September 30 at EUR 15.70 billion, up from EUR 14.33 billion in the prior-year period. Five analysts expected earnings per share of EUR 0.398, versus EUR 0.190 a year earlier, a projected increase of 109.47 percent.

That comparison gives investors two separate measures of the BASF story. The operating rebound is visible in the earnings forecast, while the Evonik proposal adds a capital-allocation question before the report arrives. The company has said the course and outcome of the exploratory talks remain open.

Dates set the next decision points

BASF's investor calendar lists October 28, 2026, for the third-quarter results and November 23 to November 24, 2026, for its Capital Markets Day. The company also identifies the written third-quarter information as available on October 28, 2026, at 7:00 a.m. CET through its investor-relations calendar.

Stock trades above the Xetra close

The Lang & Schwarz quote places BASF at EUR 52.55 on October 14, 2026, at 1:06 p.m. CEST, 2.20 percent above the Xetra close of October 13, 2026 at EUR 51.42. The 52-week range is EUR 41.48 to EUR 55.05, and the market capitalization is EUR 45.4 billion as of October 14, 2026.

The further course of trading is shown by the continuously updated real-time quote of BASF stock.